Indian market for these drugs has grown to nearly Rs 600 crore and is expected to keep growing. Weight-loss drugs are ...

As Lars Fruergaard Jørgensen steps, Novo Nordisk seeks new leadership while production hurdles impact the competitive ...

In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations.

Ozempic and Wegovy maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday over concerns the company is losing its first-mover advantage in the highly competitive obesity drug market.

(Reuters) -Ozempic-maker Novo Nordisk on Friday ousted ... both companies pursued and developed techniques to produce pharmaceutical products using fermentation. Mads Ovlisen served as CEO of ...

A leading expert has sounded a warning bell for users of Ozempic, Mounjaro and Wegovy to be aware the popular drugs can set off the agonising shingles virus. Chairwoman of the peak body for GPs ...

People who take weight-loss jabs to shift some pounds pile it all back on within 10 months of stopping, a study found. Scientists at Oxford University discovered the effects of GLP-1 drugs like ...

Sharon Osbourne stepped out in LA yesterday looking unrecognisable after her claim that Ozempic has had an adverse effect on her health. The former X Factor judge revealed she lost 42lb after she ...